Stock Price Forecast

Nov. 16, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Athersys Inc chart...

About the Company

athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. we are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. this pipeline includes both stem cell therapy and pharmaceuticals.

CEO

Gil Van Bokkelen

Exchange

OTC MARKETS

Website

http://www.athersys.com/

$0M

Total Revenue

81

Employees

$0M

Market Capitalization

0.00

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ATHX News

Athersys Inc ATHXQ

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Why Athersys Shares Are Falling During Tuesday's Session

11mon ago, source: Hosted on MSN

Athersys Inc (NASDAQ: ATHX) shares are trading lower by 12.94% to $0.98 Tuesday morning. The company announced a $3.7 million registered direct offering and concurrent private placement.

Athersys Inc Stock (OTC:ATHX), Insider Trading Activity

26d ago, source: Benzinga.com

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades ...

Athersys, Inc. Common Stock (ATHX)

6y ago, source: Nasdaq

Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month. Nasdaq provides call ...

Athersys Goes Public Through Reverse Merger, Raises $65M

1mon ago, source: BioWorld

Shares of Corbus Pharmaceuticals Inc. (NASDAQ:CRBP) doubled on opening Jan. 26 and ended the day up a whopping 249% as investors got a look at data from a ...

Athersys (ATHX) Stock Plummets to 52-Week Low as Stroke Therapy Fails Mid-Stage Trial

8y ago, source: TheStreet.com

Shares of Athersys (ATHX) plunged more than 55% to a one-year low of 90 cents on Friday after the biotech company's stem-cell therapy to treat strokes failed a mid-stage study. Shares of Athersys ...

Here’s Why Athersys (ATHX) Stock is Jumping Today

8y ago, source: TheStreet.com

Athersys (ATHX) stock is up after the company announced positive results from the analysis of one year follow-up data from a Phase 2 study of its therapy for ischemic strokes. Athersys (ATHX ...

Athersys (ATHXQ) Earnings Dates & Reports

4mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Evelo Biosciences, Inc. (EVLO)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Search Results

2mon ago, source: The Business Journals

Crafts retailer Joann Inc. has added an expert at turning around companies to its board amid reports of impending bankruptcy.… Commercial tenants continue to be interested in leasing downtown ...

Athersys, Inc. (ATHXQ)

2mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...